# Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

> **NCT03960385** · — · COMPLETED · sponsor: **Albert B. Sabin Vaccine Institute** · enrollment: 1854 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** CYD-TDV

## Key facts

- **NCT ID:** NCT03960385
- **Lead sponsor:** Albert B. Sabin Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 1854 (ACTUAL)
- **Last updated:** 2020-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960385, "Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03960385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*